R&D SOS
New at Reason: Ron Bailey investigates how Medicare drug price controls would dry up money for pharmaceutical research and development.
New at Reason: Ron Bailey investigates how Medicare drug price controls would dry up money for pharmaceutical research and development.
New from Reason: a look into what Javier Milei has accomplished and what it will take to make the most of Argentina’s window for real change. Out now for subscribers.